Setrusumab vs Bisphosphonates in Pediatric Subjects With Osteogenesis Imperfecta

Summary

The primary objective of the study is to evaluate the effect of setrusumab vs intravenous bisphosphonates (IV-BP) on reduction in fracture rate, including morphometric vertebral fractures in pediatric participants.

Timeline

Start

2023-06-14

Primary completion

2025-10-23

Completion

2027-04

Drugs

Indications